136 related articles for article (PubMed ID: 34685704)
1. The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells.
Ortiz-Hernandez GL; Sanchez-Hernandez ES; Ochoa PT; Elix CC; Alkashgari HR; McMullen JRW; Soto U; Martinez SR; Diaz Osterman CJ; Mahler M; Roy S; Casiano CA
Cells; 2021 Oct; 10(10):. PubMed ID: 34685704
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells.
Sanchez-Hernandez ES; Ochoa PT; Suzuki T; Ortiz-Hernandez GL; Unternaehrer JJ; Alkashgari HR; Diaz Osterman CJ; Martinez SR; Chen Z; Kremsky I; Wang C; Casiano CA
Cells; 2023 Aug; 12(16):. PubMed ID: 37626856
[TBL] [Abstract][Full Text] [Related]
3. Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.
Sharma S; Čermáková K; De Rijck J; Demeulemeester J; Fábry M; El Ashkar S; Van Belle S; Lepšík M; Tesina P; Duchoslav V; Novák P; Hubálek M; Srb P; Christ F; Řezáčová P; Hodges HC; Debyser Z; Veverka V
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7053-E7062. PubMed ID: 29997176
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Lens Epithelium-Derived Growth Factor p75 Dimerization on Its Tethering Function.
Brouns T; Lux V; Van Belle S; Christ F; Veverka V; Debyser Z
Cells; 2024 Jan; 13(3):. PubMed ID: 38334618
[TBL] [Abstract][Full Text] [Related]
5. LEDGF/p75-mediated chemoresistance of mixed-lineage leukemia involves cell survival pathways and super enhancer activators.
Canella A; Van Belle S; Brouns T; Nigita G; Carlon MS; Christ F; Debyser Z
Cancer Gene Ther; 2022 Feb; 29(2):133-140. PubMed ID: 33795806
[TBL] [Abstract][Full Text] [Related]
6. LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis.
El Ashkar S; Schwaller J; Pieters T; Goossens S; Demeulemeester J; Christ F; Van Belle S; Juge S; Boeckx N; Engelman A; Van Vlierberghe P; Debyser Z; De Rijck J
Blood; 2018 Jan; 131(1):95-107. PubMed ID: 29084774
[TBL] [Abstract][Full Text] [Related]
7. LEDGINs, Inhibitors of the Interaction Between HIV-1 Integrase and LEDGF/p75, Are Potent Antivirals with a Potential to Cure HIV Infection.
Debyser Z; Bruggemans A; Van Belle S; Janssens J; Christ F
Adv Exp Med Biol; 2021; 1322():97-114. PubMed ID: 34258738
[TBL] [Abstract][Full Text] [Related]
8. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
Qian S; Zhang S; Wu Y; Ding Y; ; Li X
Chemotherapy; 2020; 65(5-6):125-133. PubMed ID: 33238278
[TBL] [Abstract][Full Text] [Related]
9. Over-Expression of LEDGF/p75 in HEp-2 Cells Enhances Autoimmune IgG Response in Patients with Benign Prostatic Hyperplasia-A Novel Diagnostic Approach with Therapeutic Consequence?
Liedtke V; Rose L; Hiemann R; Nasser A; Rödiger S; Bonaventura A; Winkler L; Sowa M; Stöckle M; Schierack P; Junker K; Roggenbuck D
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047137
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
Iannelli F; Roca MS; Lombardi R; Ciardiello C; Grumetti L; De Rienzo S; Moccia T; Vitagliano C; Sorice A; Costantini S; Milone MR; Pucci B; Leone A; Di Gennaro E; Mancini R; Ciliberto G; Bruzzese F; Budillon A
J Exp Clin Cancer Res; 2020 Oct; 39(1):213. PubMed ID: 33032653
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance.
Martinez SR; Elix CC; Ochoa PT; Sanchez-Hernandez ES; Alkashgari HR; Ortiz-Hernandez GL; Zhang L; Casiano CA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108293
[TBL] [Abstract][Full Text] [Related]
12. Use of miR‑145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer.
Zhu J; Qin P; Cao C; Dai G; Xu L; Yang D
Oncol Rep; 2021 Mar; 45(3):963-974. PubMed ID: 33650661
[TBL] [Abstract][Full Text] [Related]
13. NOTCH3 promotes docetaxel resistance of prostate cancer cells through regulating TUBB3 and MAPK signaling pathway.
Sun X; Zhang Y; Xin S; Jin L; Cao Q; Wang H; Wang K; Liu X; Tang C; Li W; Li Z; Wen X; Yang G; Guo C; Liu Z; Ye L
Cancer Sci; 2024 Feb; 115(2):412-426. PubMed ID: 38115797
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes.
Eidahl JO; Crowe BL; North JA; McKee CJ; Shkriabai N; Feng L; Plumb M; Graham RL; Gorelick RJ; Hess S; Poirier MG; Foster MP; Kvaratskhelia M
Nucleic Acids Res; 2013 Apr; 41(6):3924-36. PubMed ID: 23396443
[TBL] [Abstract][Full Text] [Related]
15. ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance.
Lee CJ; Lee H; Kim SR; Nam SB; Lee GE; Yang KE; Lee GJ; Chun SH; Kang HC; Lee JY; Lee HS; Cho SJ; Cho YY
Cell Death Dis; 2024 Apr; 15(4):274. PubMed ID: 38632244
[TBL] [Abstract][Full Text] [Related]
16. Virological and cellular roles of the transcriptional coactivator LEDGF/p75.
Llano M; Morrison J; Poeschla EM
Curr Top Microbiol Immunol; 2009; 339():125-46. PubMed ID: 20012527
[TBL] [Abstract][Full Text] [Related]
17. rRNA-Derived Small RNA rsRNA-28S Regulates the Chemoresistance of Prostate Cancer Cells by Targeting PTGIS.
Qiao D; Liu Y; Lei Y; Zhang C; Bu Y; Tang Y; Zhang Y
Front Biosci (Landmark Ed); 2023 May; 28(5):102. PubMed ID: 37258478
[TBL] [Abstract][Full Text] [Related]
18. Identification of the H3K36me3 reader LEDGF/p75 in the pancancer landscape and functional exploration in clear cell renal cell carcinoma.
Zhang Y; Guo W; Feng Y; Yang L; Lin H; Zhou P; Zhao K; Jiang L; Yao B; Feng N
Comput Struct Biotechnol J; 2023; 21():4134-4148. PubMed ID: 37675289
[TBL] [Abstract][Full Text] [Related]
19. Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway.
Cheng B; Li L; Luo T; Wang Q; Luo Y; Bai S; Li K; Lai Y; Huang H
J Exp Clin Cancer Res; 2024 Mar; 43(1):67. PubMed ID: 38429845
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells.
Li X; Lu J; Kan Q; Li X; Fan Q; Li Y; Huang R; Slipicevic A; Dong HP; Eide L; Wang J; Zhang H; Berge V; Goscinski MA; Kvalheim G; Nesland JM; Suo Z
Sci Rep; 2017 Jul; 7(1):5081. PubMed ID: 28698547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
